Home
About
Overview
Sharing Data
ORCID
Help
History (18)
Drug and Gene Delivery using Sonoporation for Cardiovascular Disease.
In-vitro resistance to zidovudine and alpha-interferon in HIV-1 isolates from patients: correlations with treatment duration and response.
Anisomycin
Serine C-Palmitoyltransferase
What influences placebo and nocebo responses in Parkinson's disease?
See All 18 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
What influences placebo and nocebo responses in Parkinson's disease?
What influences placebo and nocebo responses in Parkinson's disease? Mov Disord. 2018 08; 33(8):1204-1212.
View in:
PubMed
subject areas
Catechol O-Methyltransferase
History, 18th Century
History, 19th Century
Humans
Nocebo Effect
Parkinson Disease
Placebo Effect
Polymorphism, Single Nucleotide
Treatment Outcome